In the current study, we observed that DLBCL patients treated with R-CHOP carrying the rs2231137 GG genotype displayed a poorer PFS and EFS compared to patients who carried the AA or GG genotype. This evidence concerns the gene DDIT3 and diffuse large B-cell lymphoma.